Companies /Consumer Cyclical

Amcor Plc

NYSE: AMCR Packaging & Containers
$45.15
▼ $0.09 (−0.20%) today
Markets closed · 8:03pm ET

Q3 2025 Earnings

Reported Apr 30, 2025, 4:16pm ET · SEC source
$0.18
Miss −1.64%
EPS · est. $0.18
$3.3B
Miss −3.88%
Revenue · est. $3.5B
−6.5%
Trailing market
AMCR vs S&P since report
3 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−2%0Apr 30May 1report 4:16pm ETearnings+0.2%−0.5%
−2%0Apr 30May 1earnings+0.2%−0.5%
AMCR −0.5%S&P 500 +0.2%
−2%0+2%Apr 30May 1report 4:16pm ETearnings+0.2%−0.5%
−2%0+2%Apr 30May 1earnings+0.2%−0.5%
AMCR −0.5%NASDAQ +0.2%
−2%0+2%Apr 29May 8report 4:16pm ETearnings+1.2%+0.4%
−2%0+2%Apr 29May 8earnings+1.2%+0.4%
AMCR +0.4%S&P 500 +1.2%
−4%−2%0+2%Apr 29May 8report 4:16pm ETearnings+1.7%+0.4%
−4%−2%0+2%Apr 29May 8earnings+1.7%+0.4%
AMCR +0.4%NASDAQ +1.7%
−1.30%
Day of report
+2.64%
Next session
+0.99%
One week
+0.22%
30 days

S&P 500 over the same 30 days: +6.74%.

Did AMCR Beat Earnings? Q3 2025 Results

Amcor delivered a mixed fiscal third quarter, missing on both the top and bottom lines even as it closed its landmark merger with Berry Global ahead of schedule. The packaging giant posted adjusted EPS of $0.18, a 1.64% shortfall versus the $0.18 consensus estimate, while net sales of $3.33 billion fell 2.3% year over year and came in 3.88% below expectations. The primary culprits were foreign exchange headwinds of roughly 2% and a sharper-than-anticipated drop in North America beverage volumes within the Rigid Packaging segment, which saw comparable constant currency sales decline 12%. On a brighter note, healthcare destocking in the Flexibles segment is now essentially complete, and underlying volumes grew across Europe, Asia, and Latin America. The closing of the Berry Global transaction on April 30 creates a combined entity with approximately $23 billion in annual sales and $650 million in targeted synergies over three years. Looking ahead, Amcor narrowed its fiscal 2025 adjusted EPS guidance to approximately $0.72 to $0.74, with adjusted free cash flow targeted between $900 million and $1 billion.

Key Takeaways
  • Strong cost performance across both segments
  • Improving price/mix trends driven by healthcare volume recovery
  • Volumes in line with prior year with modest share gains offsetting weak consumer demand
  • Low-to-mid single digit volume growth across Europe, Asia, and Latin America

“Today is a defining day for Amcor as we closed our transformational merger with Berry Global. Through this combination, Amcor has enhanced positions in attractive categories, a broader, more complete customer offering and expanded material science and innovation capabilities. As a result, we believe we are now uniquely positioned to deliver more consistent and sustainable organic growth and further improve margins, in line with our strategy.”

Amcor CEO, on the earnings call

Forward Guidance & Outlook

For fiscal year ending June 30, 2025 (inclusive of merger-related impacts in May and June): Adjusted EPS range narrowed to approximately 72 to 74 cents per share; Adjusted Free Cash Flow of approximately $900 million to $1,000 million. For fiscal 2026, the company expects delivery of approximately $260 million of pre-tax synergies to drive adjusted EPS accretion of approximately 12%, before taking into account organic performance in the underlying business. The company expects leverage of approximately 3.4x at June 30, 2025 and approximately 3.0x by June 30, 2026.

AMCR YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$1.0B$2.0B$3.0B$3.4B$3.3BRevenue$692.0M$654.0MGross Profit$307.0M$313.0MOperating Income$187.0M$196.0MNet Income
$0$1.0B$2.0B$3.0BRevenueGross ProfitOperating IncomeNet Income

AMCR Revenue by Segment

Global Flexible Packaging Solutions$2.6B+1.0%
Global Rigid Packaging Solutions$728.0M−3.0%

Figures from SEC filings and company reports. Not investment advice.